Provider Education | Media/Press | Patients
Each year brings important updates to how women in the
United States should be screened with HPV testing. The importance of
testing for high risk HPV types in specific clinical
scenarios have been well established and recent data
have demonstrated the importance of identification of specific HPV
types. The FDA has approved a HPV 16 and 18
genotyping test, and in order to assist clinicians with
national utilization of this new test, the ASCCP has put forth a guideline with an algorithm, as well as additional educational information on how
to appropriately use this test in women 30 years of age or older.
EDUCATE THE EDUCATORS: HPV AND THE HPV VACCINES PROGRAM (Non-CME)
| The ASCCP has expanded our Educate the
Educators program by initiating a series of periodic updates. This has included PDFs of the articles, as well as
a commentary prepared by the Educate the Educators
editorial committee. The commentary not only provides a synopsis of the
key findings, but also attempts to put them into context.
We are also making available for download PowerPoint
slides documenting what we believe to be the key message from these
articles. From time to time, there will also be news items
of general interest to our readership and we will cover
these in a "What's New?" section of the Literature Update. The 2009-2011
Educators Editorial Committee is composed of Mark H. Einstein, MD, Michael
A. Gold, MD, Kenneth L. Noller, MD, Katherine E. Sharpless, MD, Kate M. Stampler, DO, Colleeen Stockdale, MD, Jeffrey Waldman, MD,
and Thomas C. Wright, MD. |
|
Educate the Educators:
The HPV Vaccines
Updates and Resources
|
What is the Educate the Educators' program? In 2005,
ASCCP realized that the implementation and rational use of the then new
prophylactic HPV vaccines would require the diffusion
of expertise in HPV biology throughout the U.S. medical
community-with the greatest challenge being in the smaller and mid-sized
communities that lack clinicians who have expertise
in this area. To help meet that need, ASCCP developed
the Educate the Educators' Program, a two armed program featuring a
series of non-CME training courses and CME home study assessment
programs designed to train ASCCP members and other
providers to become local community experts and 'second generation
trainers' for Local Education Programs (LEP). The initial non-CME
formal training and webinairs are no longer offered.
Note: The non-CME 2009-2010 Educate the
Educators' Updates were produced specifically through grants received in
2008-09 from Merck & Company, Hologic, Qiagen, mtm laboratories,
and Roche. An online internet activity CME program
entitled Targeting Cervical Cancer
with the HPV Vaccines is available on the ASCCP Online CME Series.
This continuing medical education activity
best serves those licensed physicians and advanced
practice clinicians who will be counseling about and prescribing HPV
vaccines. These include clinicians who make gynecologic
diagnosis and management decisions or who provide
clinical or consultative primary care for female adolescents and women
aged 21 and older, especially clinicians in the fields
of family medicine, obstetrics and gynecology, and
pediatrics.will review those aspects of the biology, epidemiology, and
natural history of HPV that have led to the development
of vaccines and directed immunization guidelines. The
program will help providers identify which patients are most likely to
benefit from vaccination against human papillomavirus
and answer questions commonly asked by patients and
their family members, colleagues and the public about the HPV vaccine.
This CME activity also reviews recent efficacy studies
of both HPV vaccines and examines
immunization-associated adverse events reported to the FDA. Cost
effectiveness of HPV vaccination is also addressed as are some
frequently asked
questions about the vaccines. Note: The Targeting Cervical Cancer with the HPV Vaccines
course was produced specifically through grants received in 2005-06
from Merck & Company,
GlaxoSmithKline, Digene Corporation (now Qiagen), and
Roche. All other lectures in this Series were developed and produced
free of commercial support.
2006 CONSENSUS CONFERENCE ON THE MANAGEMENT OF ABNORMAL CERVICAL CANCER SCREENING TESTS
AND THE MANAGEMENT OF CIN/AIS
In 2006, ASCCP sponsored another Consensus Conference on the
Management of Abnormal Cervical Cancer Screening Tests and the Management of
CIN/AIS, updating the 2001 Consensus Guidelines.
These guidelines are currently in use in 2011. At the September 18-19, 2006 meeting in Bethesda,
delegates representing the 29 sponsoring Federal agencies and medical
organizations in the areas of gynecology, gynecologic
oncology, family practice, pathology, epidemiology, and
statistics openly discussed, debated and adopted revised guidelines.
The evidence-based guidelines addressed recent research,
with special attention paid to the implications of HPV
testing as part of combination screening and the value of modified
approaches to special groups, such as young women. The
2006 Consensus Guidelines and Algorithms -- as well as
the 2009 Clinical Update and Algorithm on HPV Genotyping -- are
available on the
Consensus Guidelines webpage.
Medical Frequently Asked Questions (FAQs) on HPV
Natural History of HPV
Diagnosis of HPV-Induced Disease
Treatment of HPV-induced Disease
Fact Sheets
Media Room
Consensus Guidelines Media Information
See also Medical FAQs (above) on the natural history, diagnosis, and treatment of HPV
Patient Education
The links and PDFs provided are for informational purposes
only. They do not constitute medical advice and are not intended to
replace professional care. Please consult your health care provider with
any questions or concerns you may have regarding your condition. The
ASCCP National Office does not provide individual consultation on cases
or diagnoses.
While you may download, print and distribute these
materials freely to your patients, they are copyrighted materials and
all rights are owned by either the ASCCP, NCI, or the CDC. Therefore, they may
not be changed, edited or altered in any way.
Please see the ASCCP
Patient Education page.
To view Adobe's Portable Document Format (PDF), you will need Adobe Acrobat Reader;
if you do not have it, click on the icon to the right to download a free copy. |
|
 |